Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica.

Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica.

BACKGROUND: Seronegative NMO is highly prevalent in non-Western countries implying the presence of as yet unknown antibodies (Ab). We investigated potential novel Ab in aquaporin-4 Ab (AQP-4-Ab) positive and negative NMO patients. METHODS: Sera of 20 NMO patients were examined for AQP-4, myelin olig...

Full description

Bibliographic Details
Main Authors:	Woodhall, M, Çoban, A, Waters, P, Ekizoğlu, E, Kürtüncü, M, Shugaiv, E, Türkoğlu, R, Akman-Demir, G, Eraksoy, M, Vincent, A, Tüzün, E
Format:	Journal article
Language:	English
Published:	2013

Similar Items

Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
by: Kitley, J, et al.
Published: (2012)

Myelin-oligodendrocyte glycoprotein antibody-mediated acute inflammatory demyelinating disease mimicking neuromyelitis optica
by: Kitley, J, et al.
Published: (2011)

Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study.
by: Kitley, J, et al.
Published: (2014)

Neuromyelitis Optica Spectrum Disorders With Aquaporin-4 and Myelin-Oligodendrocyte Glycoprotein Antibodies A Comparative Study
by: Kitley, J, et al.
Published: (2014)

MYELIN-OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY AS A CAUSE OF ACUTE DISSEMINATED ENCEPHALOMYELITIS WITH A NEUROMYELITIS OPTICA-LIKE PHENOTYPE IN ADULTS
by: Kitley, J, et al.
Published: (2012)

Features of neuromyelitis optica spectrum disorders and aquaporin-4 with myelin-oligodendrocyte glycoprotein antibodies-reply.
by: Kitley, J, et al.
Published: (2014)

Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders
by: Mader Simone, et al.
Published: (2011-12-01)

Prevalence and clinical characteristics of neuromyelitis optica spectrum disorders patients with myelin oligodendrocyte glycoprotein antibodies
by: Sato, D, et al.
Published: (2013)

Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients.
by: Akman-Demir, G, et al.
Published: (2011)

Neuromyelitis optica spectrum disorders and anti-myelin oligodendrocyte glycoprotein positive optic neuropathies
by: Patrick Murtagh, et al.
Published: (2022-07-01)

Anti-myelin Oligodendrocyte Glycoprotein in Aquaporin-4 Negative Neuromyelitis Optica Spectrum Disorder
by: Vahid Shaygannejad, et al.
Published: (2021-01-01)

Novel Anti-Neuronal Antibodies in Neuromyelitis Optica Patients with or without Aquaporin-4 Antibodies
by: Cavus, F, et al.
Published: (2013)

Devic's neuromyelitis optica: Prognostic implications of NMO IgG status in Turkish patients
by: Akman-Demir, G, et al.
Published: (2008)

Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease
by: Alessandro Dinoto, et al.
Published: (2022-03-01)

Retinal structural and microvascular changes in myelin oligodendrocyte glycoprotein antibody disease and neuromyelitis optica spectrum disorder: An OCT/OCTA study
by: Yanlin Lang, et al.
Published: (2023-01-01)

Pathogenesis of autoimmune demyelination: from multiple sclerosis to neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody‐associated disease
by: Joseph A Lopez, et al.
Published: (2021-01-01)

Myelin oligodendrocyte glycoprotein antibodies in neurological disease
by: Reindl, M, et al.
Published: (2018)

Serial anti–myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes
by: Waters, P, et al.
Published: (2019)

Laser-Assisted In Situ Keratomileusis Surgery on a Patient with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease or Neuromyelitis Optica Spectrum Disorder
by: Majid Moshirfar, et al.
Published: (2023-01-01)

Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder
by: Angelika Bauer, et al.
Published: (2022-11-01)

Clinical and Prognostic Evaluation of Myelin Oligodendrocyte Glycoprotein Autoimmunity in the Central Nervous System
by: Volkan Taşdemir, et al.
Published: (2018-12-01)

104 Overlapping autoimmunity: a case of concomitant aquaporin-4 and myelin oligodendrocyte glycoprotein (MOG) antibody positivity in neuromyelitis optica spectrum disorder
by: Miriam Wronski, et al.
Published: (2021-08-01)

Myelin oligodendrocyte glycoprotein CSF testing needs testing
by: Waters, P, et al.
Published: (2019)

Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies
by: Lee, H, et al.
Published: (2019)

Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies
by: Lee, H, et al.
Published: (2018)

MRI Prognostic Factors in Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Antibody Disease
by: Rosa Cortese, et al.
Published: (2021-11-01)

MRI features of myelin oligodendrocyte glycoprotein antibody disease: a descriptive study—how it differs from neuromyelitis optica spectrum disorders and multiple sclerosis
by: J. Tom Mishael, et al.
Published: (2023-07-01)

Pathology of myelin oligodendrocyte glycoprotein antibody-associated disease: a comparison with multiple sclerosis and aquaporin 4 antibody-positive neuromyelitis optica spectrum disorders
by: Yoshiki Takai, et al.
Published: (2023-07-01)

Longitudinal analysis of myelin oligodendrocyte glycoprotein antibodies in CNS inflammatory diseases.
by: Hyun, JW, et al.
Published: (2017)

Complement activation in patients with neuromyelitis optica
by: Nytrova, P, et al.
Published: (2014)

Complement activation in patients with neuromyelitis optica.
by: Nytrova, P, et al.
Published: (2014)

White blood cell count profiles in anti-aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorder and anti-myelin oligodendrocyte glycoprotein antibody-associated disease
by: Tetsuya Akaishi, et al.
Published: (2023-04-01)

Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies
by: Haeng-Jin Lee, et al.
Published: (2018-10-01)

Serial anti–myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes
by: Waters, P, et al.
Published: (2019)

Anti myelin oligodendrocyte glycoprotein associated immunoglobulin G (AntiMOG-IgG)-associated neuromyelitis optica spectrum disorder with persistent disease activity and residual cognitive impairment
by: Lekha Pandit, et al.
Published: (2017-01-01)

Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease
by: Osman Corbali, et al.
Published: (2023-02-01)

Myelin-Oligodendrocyte Glycoprotein Antibodies Spectrum Disorders
by: Masoud Etemadifar, et al.
Published: (2017-10-01)

Myelin oligodendrocyte glycoprotein encephalomyelitis: An unusual cause of blindness
by: Nimrat Sandhu, et al.
Published: (2022-01-01)

Aquaporin-4 Gene Polymorphisms in Neuromyelitis Optica and Recurrent Optic Neuritis
by: Arman Çakar, et al.
Published: (2020-06-01)

Seizures and encephalitis in myelin oligodendrocyte glycoprotein IgG disease vs aquaporin 4 IgG disease
by: Hamid, S, et al.
Published: (2017)